Effects of lansoprazole plus amoxycillin on the cure of Helicobacter pylori infection in Japanese peptic ulcer patients

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Alimentary Pharmacology and Therapeutics

• Publication date

  1996-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-2036.1996.52194000.xPMID 8899093
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• vaccine in The Netherlands . persons vaccinated with inactivated poliovirus Poliovirus-specific immunoglobulin A in

  1997cited by this paper
• Low dose, short-term, triple therapy for helicobacter pylori associated peptic ulcer.

  1997cited by this paper
• Antibacterial Properties of Lansoprazole Alone and in Combination with Antimicrobial Agents Against Helicobacter pylori

  1995cited by this paper
• Evaluation of the Effect of Lansoprazole in Suppressing Acid Secretion Using 24-Hour Intragastric pH Monitoring

  1995cited by this paper
• Low dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers.

  1995cited by this paper
• Helicobacter pylori in peptic ulcer disease.

  1995cited by this paper
• Cure of peptic gastric ulcer associated with eradication of Helicobacter pylori. Finnish Gastric Ulcer Study Group.

  1995cited by this paper
• Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori.

  1994cited by this paper
• Evidence for the essential role of Helicobacter pylori in gastric ulcer disease.

  1994cited by this paper
• The role of omeprazole and antibiotic combinations in the eradication of Helicobacter pylori--an update.

  1994cited by this paper
• Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success.

  1994cited by this paper
• Review article: Helicobacter pylori eradication–understandable caution but no excuse for inertia

  1994cited by this paper
• Long-term consequences of Helicobacter pylori eradication.

  1994cited by this paper
• Patient factors affecting Helicobacter pylori eradication with triple therapy.

  1993cited by this paper
• Intragastric pH monitoring.

  1993cited by this paper
• Identification and characterization of an ATPase system of Helicobacter pylori and the effect of proton pump inhibitors.

  1993cited by this paper
• Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori.

  1993cited by this paper
• Effect of Treatment of Helicobacter pylori Infection on the Long-term Recurrence of Gastric or Duodenal Ulcer

  1992cited by this paper
• High dose omeprazole treatment combined with amoxicillin eradicates Helicobacter pylori

  1992cited by this paper
• Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.

  1992cited by this paper
• Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.

  1992cited by this paper
• Study designs and diagnostic criteria need standardization to effectively compare worldwide ulcer trends.

  1991cited by this paper
• Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori

  1991cited by this paper
• Cure of duodenal ulcer after eradication of Helicobacter pylori

  1990cited by this paper
• Cure of peptic ulcer associated with eradication of Helicobacter pylori.

  1990cited by this paper
• Prevalence of peptic ulcer in India: an endoscopic and epidemiological study in urban Kashmir.

  1989cited by this paper
• Campylobacter pylori

  1988cited by this paper
• Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.

  1988cited by this paper
• Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

  1988cited by this paper
• Campylobacter pyloridis-associated chronic active antral gastritis.

  1988cited by this paper
• Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study.

  1987cited by this paper
• The incidence of duodenal and gastric ulcers in a large health maintenance organization.

  1985cited by this paper
• Unidentified curved bacilli on gastric epithelium in active chronic gastritis.

  1983cited by this paper
• UNIDENTIFIED CURVED BACILLI ON GASTRIC EPITHELIUM IN ACTIVE CHRONIC GASTRITIS

  1983cited by this paper
• Prophylactic effect of cimetidine in duodenal ulcer disease.

  1978cited by this paper

• Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people.

  2016cites this paper
• Helicobacter pylori: present status and future prospects in Japan

  2007cites this paper
• Eradication Therapy in Helicobacter pylori Positive Peptic Ulcer Disease: Systematic Review and Economic Analysis

  2004cites this paper
• Evaluation of the cost‐effectiveness of Helicobacter pylori eradication triple therapy vs. conventional therapy for ulcers in Japan

  2001cites this paper
• A meta‐analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori‐associated gastric or duodenal ulcer

  2001cites this paper
• [Pharmacological study on the pathological changes of the gastric mucosa in Helicobacter pylori-infected Mongolian gerbils].

  2001cites this paper
• Evaluation of the cost-effectiveness of Helicobacter pylori eradication triple therapy vs. conventional therapy for ulcers in Japan

  2001cites this paper
• High‐dose ecabet sodium improves the eradication rate of Helicobacter pylori in dual therapy with lansoprazole and amoxicillin

  2000cites this paper
• Cure of Helicobacter pylori-associated ulcer disease through eradication.

  2000cites this paper
• Helicobacter pylori‐positive duodenal ulcer: three‐day antibiotic eradication regimen

  2000cites this paper
• Prospective evaluation of a new anti‐ulcer agent, ecabet sodium, for the treatment of Helicobacter pylori infection

  1998cites this paper
• Evaluation of a new ultrashort triple therapy for Helicobacter pylori disease

  1998cites this paper
• Efficacy of Lansoprazole in Eradicating Helicobacter pylori: A Meta‐Analysis

  1998cites this paper
• Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients.

  1998cites this paper
• A Four-Day Low Dose Triple Therapy Regimen for the Treatment of Helicobacter pylori Infection

  1998cites this paper
• 3. Helicobacter pylori感染症の診断と治療

  1998cites this paper
• Incidence ofHelicobacter pylori infections and therapy for anastomotic ulcers and residual gastritis in patients with residual stomachs

  1997cites this paper
• Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders.

  1997cites this paper